Investment Summary

1315 Capital Invests In JDS Therapeutics

On October 22, 2015, growth capital firm 1315 Capital invested in life science company JDS Therapeutics

Investment Highlights
  • This is 1315 Capital’s 1st transaction in the Life Science sector.
  • This is 1315 Capital’s 4th transaction in the United States.
  • This is 1315 Capital’s 1st transaction in New York.

Investment Summary
Date 2015-10-22
Target JDS Therapeutics
Sector Life Science
Investor(s) 1315 Capital
Deal Type Venture

Target

JDS Therapeutics

Purchase, New York, United States
JDS Therapeutics is a specialty pharmaceutical company that develops, manufactures and markets products for women’s health. JDS’s wholly-owned subsidiary, Nutrition 21, is a leader in the nutritional supplement industry. Nutrition 21 is a developer and marketer of efficacious, highvalue, clinically substantiated ingredients for dietary supplements, medical foods and beverages, including Chromax® chromium picolinate and Nitrosigine® bonded arginine silicate. JDS and Nutrition 21 currently hold over 100 issued and pending patents on natural, bioactive compounds that support human health and sports nutrition. JDS Therapeutics was founded in 2011 and is based in Purchase, New York.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

1315 Capital

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2014
Size Small
Type Sector Focused
DESCRIPTION

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $40 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 4 of 21
Sector (Life Science) 1 of 6
Type (Venture) 3 of 6
State (New York) 1 of 1
Country (United States) 4 of 19
Year (2015) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-06 Onkos Surgical

Parsippany, New Jersey, United States

Onkos Surgical is a privately held surgical oncology start-up. Onkos Surgical believes surgical oncology deserves attention, focus and innovation. Through dedication and strategic partnerships, Onkos Surgical will advance surgical oncology solutions and will advocate for and support the surgeons and caregivers that dedicate their lives to the surgical treatment of cancer. Onkos Surgical was founded in 2015 and is based in Parsippany, New Jersey.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-15 Encore Dermatology

Malvern, Pennsylvania, United States

Encore Dermatology is a privately held fully-integrated specialty dermatology company with a mission committed to delivering innovative prescription therapies and medical devices to dermatologists focusing on customer service and improving the quality-of-life of patients. Encore Dermatology was founded in 2014 and is based in Malvern, Pennsylvania.

Buy -
Mergr

Product

Company

Legal